Clinical Trials for Symbio Pharmaceuticals

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Symbio Pharmaceuticals

Clinical Trials (2)

NCT06761677
A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
PHASE1/PHASE2Recruiting
43 participants
Started: Jun 9, 2025 · Completed: May 8, 2029
1 condition1 sponsor8 locations
NCT04706923
A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
PHASE2Recruiting
52 participants
Started: Aug 16, 2021 · Completed: Sep 30, 2026
2 conditions1 sponsor11 locations